Dengue Control on an Island in the Gulf of Thailand

II. Virological Studies

Thomas J. Smith Medical Research Laboratory, SEATO Medical Project, Rajavithi Road, Faculty of Public Health, Mahidol University, Bangkok, Thailand

Search for other papers by Thomas J. Smith in
Current site
Google Scholar
PubMed
Close
,
Phillip E. Winter Medical Research Laboratory, SEATO Medical Project, Rajavithi Road, Faculty of Public Health, Mahidol University, Bangkok, Thailand

Search for other papers by Phillip E. Winter in
Current site
Google Scholar
PubMed
Close
,
Ananda Nisalak Medical Research Laboratory, SEATO Medical Project, Rajavithi Road, Faculty of Public Health, Mahidol University, Bangkok, Thailand

Search for other papers by Ananda Nisalak in
Current site
Google Scholar
PubMed
Close
, and
Suchinda Udomsakdi Medical Research Laboratory, SEATO Medical Project, Rajavithi Road, Faculty of Public Health, Mahidol University, Bangkok, Thailand

Search for other papers by Suchinda Udomsakdi in
Current site
Google Scholar
PubMed
Close
Restricted access

A dengue vector-control program was conducted on Koh Samui, an island in the Gulf of Thailand, in 1968. Virus-isolation data gathered in support of this program indicated that a single dengue serotype, dengue-4, was active at the time; 63 dengue isolates from mosquitoes and 2 from patients were identified as type 4, the same serotype that prevailed on the island in 1967. Variability was noted in neutralization of many strains by a single lot of type-specific immune serum, as had been observed in previous studies of low-passage tissue-culture strains of dengue virus. Dengue viruses were isolated from both Aedes aegypti and Aedes albopictus, the former having the higher infection rate. All dengue isolates were made from in or around homes of patients with laboratory evidence of dengue infection. The sensitivity of the LLC-MK2 delayed-plaque system was emphasized in these studies since only 66.7% of isolates were recovered with the standard plaque assay.

Author Notes

Deceased. Please direct reprint requests to Dr. Winter.

Present address: Preventive Medicine Division, Office of The Surgeon General, Washington, D. C. 20314.

U.S. mailing address: SEATO Medical Project, U.S. Component, APO San Francisco, California 96346.

Save